ZHX3

ZHX3 is a ubiquitously expressed nuclear transcriptional repressor that controls target gene expression through dimerization within the ZHX family and engagement of the transcription factor NF-Y (PMID:12659632). It contains two zinc-finger motifs and five homeodomains; its HD1 region carries the overlapping dimerization, NF-YA-interaction, and repressor activities, while nuclear localization signals map to the N-terminal/Znf1 and HD2 regions (PMID:12659632). ZHX3 homodimerizes and heterodimerizes with other ZHX family members, including ZHX1 (PMID:12659632) and ZHX2 (PMID:14659886), and binds the activation domain of NF-YA to repress transcription (PMID:12659632). Functionally, ZHX3 represses the promoters of the metabolic/cancer marker genes PKM and HKII in hepatocytes (PMID:19273305) and represses RGS2 to promote migration and invasion of urothelial bladder carcinoma cells (PMID:33440047). ZHX3 protein levels are controlled by the E3 ubiquitin ligase TRIM21, which ubiquitinates ZHX3 and targets it for degradation (PMID:33440047).

1. 2003 High

   Established ZHX3's core identity by showing it is a nuclear repressor that dimerizes and contacts the general transcription factor NF-Y, defining the molecular surfaces through which it acts.

   Evidence Yeast two-hybrid screen, in vitro/in vivo interaction assays, and domain-mapping/deletion analysis of cloned ZHX3

   PMID:12659632

   Open questions at the time

   • No direct DNA-binding site or target promoter identified at this stage
   • Repression mechanism downstream of NF-YA binding not defined
   • No endogenous target genes characterized
2. 2003 High

   Extended the ZHX dimerization network by demonstrating ZHX3 heterodimerizes with ZHX2 through the HD1 domain, establishing combinatorial partnering within the family.

   Evidence Reciprocal in vitro and in vivo interaction assays with mouse ZHX2 and ZHX3 cDNAs

   PMID:14659886

   Open questions at the time

   • Functional consequence of ZHX2-ZHX3 heterodimers on transcription not measured
   • Relative affinities and preference among homo- vs heterodimers unknown
3. 2009 Medium

   Connected ZHX3 to specific gene targets by showing it represses the PKM and HKII promoters, providing the first defined endogenous-relevant transcriptional outputs.

   Evidence Luciferase reporter assays with PKM and HKII promoter regions in hepatoma cell lines

   PMID:19273305

   Open questions at the time

   • Reporter assay only; direct binding to these promoters not shown
   • Single lab, single method
   • Effect on endogenous PKM/HKII expression and metabolism not established
4. 2021 Medium

   Defined how ZHX3 abundance is controlled and linked its repressor activity to cancer cell behavior by identifying TRIM21 as the ubiquitin ligase degrading ZHX3 and RGS2 as a repressed target driving invasion.

   Evidence CoIP plus mass spectrometry for TRIM21, RNA-seq for RGS2 repression, and in vitro/in vivo migration and invasion assays in bladder urothelial carcinoma cells

   PMID:33440047

   Open questions at the time

   • Direct ZHX3 occupancy of the RGS2 promoter not demonstrated
   • TRIM21 ubiquitination site(s) on ZHX3 and signals regulating this degradation unknown
   • Single lab; reciprocal validation of binding partners limited

• How ZHX3 selects its DNA targets and whether its repression depends on chromatin-modifying cofactors beyond NF-Y interaction remains unresolved.
• No defined ZHX3 DNA-binding consensus despite zinc fingers and homeodomains
• Co-repressor machinery executing repression not identified
• Genome-wide direct binding map (e.g. ChIP-seq) absent